
Please try another search
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Mark B. Saldanha | 52 | 2015 | Non-Independent Executive Chairman & MD |
Varddhaman Vikramaditya Jain | - | 2019 | - |
Abhinna Sundar Mohanty | 72 | 2019 | Non-Executive & Independent Director |
Digant Mahesh Parikh | 53 | 2018 | Non-Executive Independent Director |
Sunny Sharma | 51 | 2021 | Non-Executive & Non-Independent Director |
Shailaja Vardhan | 58 | 2023 | Non-Executive & Independent Director |
Srinivas Mishra | - | 2025 | Independent Director |
Varddhman Vikramaditya Jain | 55 | 2019 | Whole-Time Executive Non Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review